|
 |
HISTORY OF MEDICINE |
|
Year : 2011 | Volume
: 12
| Issue : 1 | Page : 42 |
|
|
Animal testing and medicine
Rachel Hajar
Department of Cardiology and Cardiothoracic Surgery, Hamad Medical Corporation, Doha, Qatar
Date of Web Publication | 25-May-2011 |
Correspondence Address: Rachel Hajar Director of Non-Invasive Cardiology Section, Department of Cardiology and Cardiothoracic Surgery, Hamad Medical Corporation, P.O. Box 3050, Doha Qatar
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1995-705X.81548
How to cite this article: Hajar R. Animal testing and medicine. Heart Views 2011;12:42 |
"The greatness of a nation and its moral progress can be judged by the way its animals are treated."
- Mahatma Gandhi
Animals have been used repeatedly throughout the history of biomedical research. Early Greek physician-scientists, such as Aristotle, (384 - 322 BC) and Erasistratus, (304 - 258 BC), performed experiments on living animals. Likewise, Galen (129 - 199 / 217 AD), a Greek physician who practiced in Rome and was a giant in the history of medicine, conducted animal experiments to advance the understanding of anatomy, physiology, pathology, and pharmacology. Ibn Zuhr (Avenzoar), an Arab physician in twelfth century Moorish Spain, introduced animal testing as an experimental method for testing surgical procedures before applying them to human patients.
In recent years, the practice of using animals for biomedical research has come under severe criticism by animal protection and animal rights groups. Laws have been passed in several countries to make the practice more 'humane'. Debates on the ethics of animal testing have raged since the seventeenth century. Theodore Roosevelt in the nineteenth century stated, "Common sense without conscience may lead to crime, but conscience without common sense may lead to folly, which is the handmaiden of crime."
Those against, contend that the benefit to humans does not justify the harm to animals. Many people also believe that animals are inferior to humans and very different from them, hence results from animals cannot be applied to humans. Those in favor of animal testing argue that experiments on animals are necessary to advance medical and biological knowledge. Claude Bernard, known as the father of physiology, stated that "experiments on animals are entirely conclusive for the toxicology and hygiene of man. The effects of these substances are the same on man as on animals, save for differences in degree". Bernard established animal experimentation as part of the standard scientific method.
Drug testing using animals became important in the twentieth century. In 1937, a pharmaceutical company in the USA created a preparation of sulfanilamide, using diethylene glycol (DEG) as a solvent, and called the preparation 'Elixir Sulfanilamide'. DEG was poisonous to humans, but the company's chief pharmacist and chemist was not aware of this. He simply added raspberry flavoring to the sulfa drug, which he had dissolved in DEG, and the company marketed the product. The preparation led to mass poisoning causing the deaths of more than a hundred people. No animal testing was done. The public outcry caused by this incident and other similar disasters led to the passing of the 1938 Federal Food, Drug, and Cosmetic Act requiring safety testing of drugs on animals before they could be marketed.
Another tragic drug fiasco occurred in the late 1950s and early 1960s with thalidomide. It was found to act as an effective tranquilizer and painkiller and was proclaimed a 'wonder drug' for insomnia, coughs, colds, and headaches. It was found to have an inhibitory effect on morning sickness, and hence, thousands of pregnant women took the drug to relieve their symptoms. Consequently, more than 10,000 children in 46 countries were born with malformations or missing limbs (phocomelia, from the Greek meaning 'limb'). The drug was withdrawn in 1961 and 1968 after a long campaign.
The above-mentioned incidents and others illustrate the harm to humans from the use of substances that have not been first tested on animals and underline the importance of animal experimentation to avert or prevent human tragedy. The practice of using animals in biomedical research has led to significant advances in the treatment of various diseases.
Issues such as 'cruelty' to animals and the humane treatment of animals are valid concerns, and hence, the use of animals in experimentation is greatly regulated. This has led to the 3Rs campaign, which advocates the search (1) for the replacement of animals with non-living models; (2) reduction in the use of animals; and (3) refinement of animal use practices. However, total elimination of animal testing will significantly set back the development of essential medical devices, medicines, and treatment. By employing the 3Rs when continuing to use animals for scientific research, the scientific community can affirm its moral conscience as well as uphold its obligation to humanity to further the advancement of science for civilization and humanity.
This article has been cited by | 1 |
Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies |
|
| Mikkel Bo Brent | | Pharmacology & Therapeutics. 2023; : 108383 | | [Pubmed] | [DOI] | | 2 |
Integrating glycolysis, citric acid cycle, pentose phosphate pathway, and fatty acid beta-oxidation into a single computational model |
|
| Sylwester M. Kloska, Krzysztof Palczynski, Tomasz Marciniak, Tomasz Talaska, Beata J. Wysocki, Paul Davis, Tadeusz A. Wysoki | | Scientific Reports. 2023; 13(1) | | [Pubmed] | [DOI] | | 3 |
Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars |
|
| Sarfaraz K. Niazi, Waleed Mohammed Al-Shaqha, Zafar Mirza | | Journal of Market Access & Health Policy. 2023; 11(1) | | [Pubmed] | [DOI] | | 4 |
Three-Dimensional Bioprinting of an In Vitro Lung Model |
|
| Nádia Nascimento da Rosa, Julia Maurer Appel, Ana Carolina Irioda, Bassam Felipe Mogharbel, Nathalia Barth de Oliveira, Maiara Carolina Perussolo, Priscila Elias Ferreira Stricker, Lívia Rosa-Fernandes, Cláudio Romero Farias Marinho, Katherine Athayde Teixeira de Carvalho | | International Journal of Molecular Sciences. 2023; 24(6): 5852 | | [Pubmed] | [DOI] | | 5 |
Open-source software for automated rodent behavioral analysis |
|
| Sena Isik, Gunes Unal | | Frontiers in Neuroscience. 2023; 17 | | [Pubmed] | [DOI] | | 6 |
CATER: Combined Animal Tracking & Environment Reconstruction |
|
| Lars Haalck, Michael Mangan, Antoine Wystrach, Leo Clement, Barbara Webb, Benjamin Risse | | Science Advances. 2023; 9(16) | | [Pubmed] | [DOI] | | 7 |
Animal Models to Test SARS-CoV-2 Vaccines: Which Ones Are in Use and Future Expectations |
|
| Gabrielle Gimenes Lima, Amanda Izeli Portilho, Elizabeth De Gaspari | | Pathogens. 2022; 12(1): 20 | | [Pubmed] | [DOI] | | 8 |
Causal Criteria in Medical and Biological Disciplines: History, Essence, and Radiation Aspect. Report 3, Part 2: Hill’s Last Four Criteria: Use and Limitations |
|
| A. N. Koterov | | Biology Bulletin. 2022; 49(11): 2184 | | [Pubmed] | [DOI] | | 9 |
The Coming of Age of Biosimilars: A Personal Perspective |
|
| Sarfaraz K. Niazi | | Biologics. 2022; 2(2): 107 | | [Pubmed] | [DOI] | | 10 |
The Ontology of Oncology: Navigating Cyborgs and Assemblages Through Cancer Treatment |
|
| Jay Baglia | | Health Communication. 2022; : 1 | | [Pubmed] | [DOI] | | 11 |
Embracing Medication Needs of Patients based on Ethical, Dietary, and Religious Preferences |
|
| Lena Tieu, Jasmine Uchi, Nirva Patel, Mihir Meghani, Padmaja Patel, Yen Nguyen | | American Journal of Lifestyle Medicine. 2022; : 1559827622 | | [Pubmed] | [DOI] | | 12 |
Queueing theory model of pentose phosphate pathway |
|
| Sylwester M. Kloska, Krzysztof Palczynski, Tomasz Marciniak, Tomasz Talaska, Marissa Miller, Beata J. Wysocki, Paul Davis, Tadeusz A. Wysocki | | Scientific Reports. 2022; 12(1) | | [Pubmed] | [DOI] | | 13 |
Manoeuvrability and biocompatibility of endodontic tricalcium silicate-based putties |
|
| Qin Sun,Meng Meng,Jeffrey N. Steed,Stephanie J. Sidow,Brian E. Bergeron,Li-na Niu,Jing-zhi Ma,Franklin R. Tay | | Journal of Dentistry. 2021; 104: 103530 | | [Pubmed] | [DOI] | | 14 |
A review of 28 free animal-tracking software applications: current features and limitations |
|
| Veronica Panadeiro,Alvaro Rodriguez,Jason Henry,Donald Wlodkowic,Magnus Andersson | | Lab Animal. 2021; | | [Pubmed] | [DOI] | | 15 |
Replacement Strategies for Animal Studies in Inhalation Testing |
|
| Eleonore Fröhlich | | Sci. 2021; 3(4): 45 | | [Pubmed] | [DOI] | | 16 |
Biosimilars: A Futuristic Fast-to-Market Advice to Developers |
|
| Sarfaraz K. Niazi | | Expert Opinion on Biological Therapy. 2021; | | [Pubmed] | [DOI] | | 17 |
Queueing theory model of Krebs cycle |
|
| Sylwester Kloska, Krzysztof Palczynski, Tomasz Marciniak, Tomasz Talaska, Marissa Nitz, Beata J Wysocki, Paul Davis, Tadeusz A Wysocki, Pier Luigi Martelli | | Bioinformatics. 2021; 37(18): 2912 | | [Pubmed] | [DOI] | | 18 |
Biologia futura: animal testing in drug development—the past, the present and the future |
|
| Miklós Sántha | | Biologia Futura. 2020; 71(4): 443 | | [Pubmed] | [DOI] | | 19 |
Assessment of Cardiotoxicity With Stem Cell-based Strategies |
|
| Aaltje Maria Stella Stoter,Marc N. Hirt,Justus Stenzig,Florian Weinberger | | Clinical Therapeutics. 2020; 42(10): 1892 | | [Pubmed] | [DOI] | | 20 |
A simple method to study motor and non-motor behaviors in adult zebrafish |
|
| Velanganni Selvaraj,Hemagowri Venkatasubramanian,K. Ilango,Kirankumar Santhakumar | | Journal of Neuroscience Methods. 2019; 320: 16 | | [Pubmed] | [DOI] | | 21 |
Remote vitals monitoring in rodents using video recordings |
|
| Janosch Kunczik,Carina Barbosa Pereira,Leonie Zieglowski,René Tolba,Laura Wassermann,Christine Häger,André Bleich,Heike Janssen,Thomas Thum,Michael Czaplik | | Biomedical Optics Express. 2019; 10(9): 4422 | | [Pubmed] | [DOI] | | 22 |
A Review of Freely Available, Open-Source Software for the Automated Analysis of the Behavior of Adult Zebrafish |
|
| Juan E. Franco-Restrepo,Diego A. Forero,Rafael A. Vargas | | Zebrafish. 2019; 16(3) | | [Pubmed] | [DOI] | | 23 |
The Scientist Citizen and the Citizen Scientist: Blurring the Lines |
|
| Lane Warmbrod,Marc Trotochaud,Nancy Connell | | ILAR Journal. 2019; 60(1): 5 | | [Pubmed] | [DOI] | | 24 |
Willingness to participate in HIV research at the end of life (EOL) |
|
| Katya Prakash,Sara Gianella,Karine Dubé,Jeff Taylor,GaYoung Lee,Davey M. Smith,Leonid Margolis | | PLOS ONE. 2018; 13(7): e0199670 | | [Pubmed] | [DOI] | | 25 |
Assessment of Cryosurgical Device Performance Using a 3D Tissue-Engineered Cancer Model |
|
| John M. Baust,Anthony Robilotto,Kristi K. Snyder,Kimberly Santucci,Jennie Stewart,Robert Van Buskirk,John G. Baust | | Technology in Cancer Research & Treatment. 2017; 16(6): 900 | | [Pubmed] | [DOI] | | 26 |
Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue |
|
| Mandy B. Esch,Hidetaka Ueno,Dawn R. Applegate,Michael L. Shuler | | Lab Chip. 2016; | | [Pubmed] | [DOI] | | 27 |
Bioprinting Organotypic Hydrogels with Improved Mesenchymal Stem Cell Remodeling and Mineralization Properties for Bone Tissue Engineering |
|
| Daniela Filipa Duarte Campos,Andreas Blaeser,Kate Buellesbach,Kshama Shree Sen,Weiwei Xun,Walter Tillmann,Horst Fischer | | Advanced Healthcare Materials. 2016; | | [Pubmed] | [DOI] | | 28 |
Prenatal Smoking and Genetic Risk: Examining the Childhood Origins of Externalizing Behavioral Problems |
|
| Melissa A. Petkovsek,Brian B. Boutwell,Kevin M. Beaver,J.C. Barnes | | Social Science & Medicine. 2014; | | [Pubmed] | [DOI] | | 29 |
Animal Models to Investigate the Pathogenesis of Rheumatic Heart Disease |
|
| Catherine M. Rush,Brenda L. Govan,Suchandan Sikder,Natasha L. Williams,Natkunam Ketheesan | | Frontiers in Pediatrics. 2014; 2 | | [Pubmed] | [DOI] | |
|
 |
 |
|